GRIFULVIN V Drug Patent Profile
✉ Email this page to a colleague
When do Grifulvin V patents expire, and what generic alternatives are available?
Grifulvin V is a drug marketed by Johnson And Johnson, Valeant Luxembourg, and J And J. and is included in four NDAs.
The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRIFULVIN V?
- What are the global sales for GRIFULVIN V?
- What is Average Wholesale Price for GRIFULVIN V?
Summary for GRIFULVIN V
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Clinical Trials: | 2 |
| Patent Applications: | 116 |
| DailyMed Link: | GRIFULVIN V at DailyMed |
Recent Clinical Trials for GRIFULVIN V
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Actavis Inc. | Phase 1 |
US Patents and Regulatory Information for GRIFULVIN V
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | GRIFULVIN V | griseofulvin, microcrystalline | SUSPENSION;ORAL | 050448-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Valeant Luxembourg | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 062279-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| J And J | GRIFULVIN V | griseofulvin, microcrystalline | TABLET;ORAL | 060618-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
